These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 5869768)
21. Experience with the use of 6-mercaptopurine and "Imuran" in the treatment of progressive hepatitis (active chronic hepatitis). Arter WJ; Perkns KW; Blackburn CR Australas Ann Med; 1966 Aug; 15(3):222-6. PubMed ID: 5989539 [No Abstract] [Full Text] [Related]
22. Experience with the use of 6-mercaptopurine and "Imuran" in the treatment of progressive hepatitis (active chronic hepatitis). Arter WJ; Perkins KW; Blackburn CR Australas Ann Med; 1966 Aug; 15(3):222-6. PubMed ID: 5986700 [No Abstract] [Full Text] [Related]
23. Genetic polymorphism and outcomes with azathioprine and 6-mercaptopurine. Gardiner SJ; Begg EJ; Barclay ML; Kirkpatrick CM Adverse Drug React Toxicol Rev; 2000 Dec; 19(4):293-312. PubMed ID: 11212460 [No Abstract] [Full Text] [Related]
24. Allopurinol safely and effectively optimizes tioguanine metabolites in inflammatory bowel disease patients not responding to azathioprine and mercaptopurine. Sparrow MP; Hande SA; Friedman S; Lim WC; Reddy SI; Cao D; Hanauer SB Aliment Pharmacol Ther; 2005 Sep; 22(5):441-6. PubMed ID: 16128682 [TBL] [Abstract][Full Text] [Related]
25. A triangulation study of the clinician and patient experiences of the use of the immunosuppressant drugs azathioprine and 6-mercaptopurine for the management of inflammatory bowel disease. Holbrook K J Clin Nurs; 2007 Aug; 16(8):1427-34. PubMed ID: 17655530 [TBL] [Abstract][Full Text] [Related]
26. [Therapy of chronic inflammatory bowel diseases with azathioprine, 6-mercaptopurine and 6-thioguanine. Clinico-pharmacologic aspects]. Schwab M; Herrlinger K; Schaeffeler E; Stange EF Dtsch Med Wochenschr; 2003 Feb; 128(8):378-85. PubMed ID: 12594624 [No Abstract] [Full Text] [Related]
28. A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate. Sandborn WJ Am J Gastroenterol; 1996 Mar; 91(3):423-33. PubMed ID: 8633486 [No Abstract] [Full Text] [Related]
29. [On therapy of granuloma gangraenescence with antimetabolites]. Ristow W; Martin H Z Laryngol Rhinol Otol; 1969 Jan; 48(1):63-70. PubMed ID: 5764171 [No Abstract] [Full Text] [Related]
30. [Indications for cytostatic treatment of patients with osteomyelosclerosis of osteomyelofibrosis]. Engelmann C; Schulz K; Nowotny P; Konrad H Dtsch Gesundheitsw; 1972 Dec; 27(50):2375-80. PubMed ID: 4651200 [No Abstract] [Full Text] [Related]
31. [Treatment of systemic lupus and other collagenoses with antilymphocyte globulins. Apropos of 10 cases]. Herreman G; Broquie G; Metzger JP; Godeau P Nouv Presse Med; 1972 Sep; 1(31):2035-9. PubMed ID: 4628759 [No Abstract] [Full Text] [Related]
32. Combining infliximab with 6-mercaptopurine/azathioprine for fistula therapy in Crohn's disease. Ochsenkühn T; Göke B; Sackmann M Am J Gastroenterol; 2002 Aug; 97(8):2022-5. PubMed ID: 12190171 [TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of thiopurinic immunomodulators (azathioprine and mercaptopurine) in steroid-dependent ulcerative colitis. Lopez-Sanroman A; Bermejo F; Carrera E; Garcia-Plaza A Aliment Pharmacol Ther; 2004 Jul; 20(2):161-6. PubMed ID: 15233695 [TBL] [Abstract][Full Text] [Related]
34. [Immunosuppressive agents: Imurel and Purinethol]. Groupe d'étude thérapeutique des affections inflammatoires digestives Rev Prat; 2005 May; 55(9):994. PubMed ID: 16052970 [No Abstract] [Full Text] [Related]
35. [Experiences with 6-mercaptopurine and methotrexate in primary chronic polyarthritis and other collagen diseases]. Beickert A; Geidel H Dtsch Gesundheitsw; 1968 Apr; 23(15):689-92. PubMed ID: 5679433 [No Abstract] [Full Text] [Related]
36. [Experiences in administration of antimetabolites in treatment of dermatomyosis]. Nebe H Dermatol Monatsschr; 1972 Jul; 158(7):497-505. PubMed ID: 5050959 [No Abstract] [Full Text] [Related]
37. [Treatment of chronic nephritis with cytostatics]. Tareeva IE; Filimonova RG; Poliantseva LR; Mukhin NA Sov Med; 1974 Nov; (11):47-53. PubMed ID: 4439074 [No Abstract] [Full Text] [Related]
38. Thiopurine methyltransferase activity combined with 6-thioguanine metabolite levels predicts clinical response to thiopurines in patients with inflammatory bowel disease. Kwan LY; Devlin SM; Mirocha JM; Papadakis KA Dig Liver Dis; 2008 Jun; 40(6):425-32. PubMed ID: 18304898 [TBL] [Abstract][Full Text] [Related]
39. [The use of immunosuppressors in Crohn disease]. Andreoli A; Prantera C Ann Ital Chir; 1994; 65(3):287-8. PubMed ID: 7887579 [No Abstract] [Full Text] [Related]